Sajeel Chowdhary

Brian T. Collins, MD is a board-certified radiation oncologist with extensive expertise in treating breast and lung cancers. Renowned for his proficiency in CyberKnife radiotherapy technology, Dr. Collins specializes in cutting-edge radiation oncology techniques and tools, offering advanced treatment options to his patients. Prior to joining Tampa General Hospital Cancer Institute, Dr. Collins served as the medical director of the Department of Radiation Medicine and clinical director of the Proton Therapy Center at MedStar Georgetown University Hospital. With over 20 years of experience, he has a particular interest in treating central nervous system (CNS) tumors and has made significant contributions to scientific journals and publications in his field.Generated from the website

Noman Ashraf, MD is a highly experienced hematologist-oncologist specializing in solid tumor oncology at Tampa General Hospital Cancer Institute. With a strong background in academic medicine, Dr. Ashraf is an associate professor of medicine at the USF Health Morsani College of Medicine and actively involved in the Hematology and Medical Oncology Fellowship Program at H. Lee Moffitt Cancer Center. He has an impressive track record of training postgraduate fellows and has been recognized as a speaker and presenter at various regional, national, and international conferences. With a medical degree from The Aga Khan University in Pakistan and residency training at Baylor College of Medicine, Dr. Ashraf brings a wealth of knowledge and expertise to his practice. He has also served as a principal investigator for clinical trials and has contributed to numerous peer-reviewed publications and book chapters in his field. Committed to providing exceptional care, Dr. Ashraf is dedicated to advancing the field of oncology through research and innovation.Generated from the website

Tampa General Hospital Cancer Institute is home to Dr. Ivan Borrello, a distinguished hematologist-oncologist and Medical Director of the Myeloma, Bone Marrow Transplant, and Cell Therapies program. With expertise in immunotherapy for hematologic malignancies and a strong background in clinical research, Dr. Borrello has made significant contributions to the field, including over 100 peer-reviewed publications. Dr. Borrello's extensive training includes a medical degree from the Medical College of Virginia and fellowships at prestigious institutions such as Johns Hopkins University. He is recognized for his leadership in developing innovative therapies for multiple myeloma and is affiliated with several prominent professional organizations in oncology and hematology. Generated from the website